Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07020182

Efficacy Of Inpatient Pulmonary Rehabilitation Program In Elderly Patients With Acute Exacerbation Of COPD

The study aimed to identify the effect of early pulmonary rehabilitation in elderly patients with Acute exacerbation (AE) of COPD (AECOPD) in exercise tolerance, dyspnea, sleep quality, fatigue, and time to discharge from hospital.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

COPD Received PR COPD COPD Acute Exacerbation Chronic Disease Disease Attributes Elderly (People Aged 65 or More) Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

65 year–78 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine for Girls- Al-Azhar-University, Cairo, Egypt

Cairo, 02, Egypt

About this study

A prospective supervised RCT (Randomized Controlled Trial) will be done include elderly COPD patients assigned randomly into two groups; Group A performed Physical therapy program, and Group B is control group completed two daily sessions from day 1 of hospital admission till discharge from the hospital .The study duration will be 12 weeks

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with acute exacerbation of COPD in both gender
  • Patient older than 65 years
  • Patient with clear consciousness
  • Patients had been diagnosed with shortness of breath or dyspnea that was not caused by heart disease, pneumothorax, or pulmonary edema

Exclusion criteria

  • Patient with systolic blood pressure lower than 90 mmHg
  • Patient with an unstable psychological status, hemoptysis, pneumothorax, pulmonary edema

Treatment and study plan

physical therapy program

Other

Group A will performed a physical therapy program that completed two daily sessions till discharge from the hospital .Exercise training starts from randomisation until hospital discharge,and administered twice per day, seven times per week. The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

Primary outcomes

  1. Exercise tolerance

    Time frame: The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

    The 6 minute walk test(6MWT)in meter to asses exercise tolerance

Secondary outcomes

  1. Dyspnea

    Time frame: The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

    (The Modified Medical Research Council (mMRC )scale to assess Dyspnea)

  2. Length of hospital stay(LOS)

    Time frame: The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

    (Number of days to assess length of stay in hospital (LOS) from admission to hospital to discharge from hospital)

  3. Fatigue level

    Time frame: The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

    Fatigue Severity Scale (FSS)to assess fatigue)

Study contacts

Contact information is provided by the study sponsor or research team.

Marwa Mohammed

CONTACT

[email protected]

Marwa Mohammed, Phd -university lecturer

CONTACT

[email protected]

+201000253865

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 13, 2025
Registry last updated
Jun 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.